Live Breaking News & Updates on Grifols Company Profile

Stay updated with breaking news from Grifols company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Grifols, S.A. (NASDAQ:GRFS) Receives $10.58 Consensus Price Target from Brokerages

Shares of Grifols, S.A. (NASDAQ:GRFS – Get Free Report) have earned an average rating of “Moderate Buy” from the six research firms that are presently covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12 […] ....

United States , Vistaseal Veraseal , Albutein Flexbag , Grifols Company Profile , Goldman Sachs Group Inc , Wells Fargo Company , Orion Portfolio Solutions , Get Free Report , Marketbeat Ratings , Portfolio Solutions , Goldman Sachs Group , Sachs Group , Get Free , Gamunexc Immune Globulin Injection , Flebogamma Immune Globulin Intravenous , Xembify Immune Globulin Subcutaneous , Immune Globulin , Lynspad Alpha , Proteinase Inhibitor , Human Albumin , Plasbumin Albumin , Grifols Daily , Nasdaq Grfs ,

Grifols (NASDAQ:GRFS) Rating Lowered to Hold at StockNews.com

StockNews.com lowered shares of Grifols (NASDAQ:GRFS – Free Report) from a buy rating to a hold rating in a research note issued to investors on Tuesday morning. Separately, Morgan Stanley upgraded Grifols from an equal weight rating to an overweight rating in a research report on Wednesday, April 12th. Four equities research analysts have rated […] ....

United States , Nova Scotia , Albutein Flexbag , Vistaseal Veraseal , Us Bancorp , Morgan Stanley , Raymond James Associates , Blackrock Inc , Advisor Group Holdings Inc , Financial Services Group Inc , Grifols Company Profile , Free Report , Group Holdings , Services Group , Get Free Report , Gamunexc Immune Globulin Injection , Flebogamma Immune Globulin Intravenous , Xembify Immune Globulin Subcutaneous , Immune Globulin , Lynspad Alpha , Proteinase Inhibitor , Human Albumin , Plasbumin Albumin , Grifols Daily , Nasdaq Grfs , Stocknews Com ,

Grifols (NASDAQ:GRFS) Shares Down 2.5%

Shares of Grifols, S.A. (NASDAQ:GRFS – Get Free Report) were down 2.5% during trading on Monday . The company traded as low as $10.23 and last traded at $10.33. Approximately 298,572 shares changed hands during trading, a decline of 66% from the average daily volume of 882,722 shares. The stock had previously closed at $10.60. […] ....

United States , Nova Scotia , Albutein Flexbag , Vistaseal Veraseal , Raymond James Associates , Advisor Group Holdings Inc , Financial Services Group Inc , Us Bancorp , Morgan Stanley , Grifols Company Profile , Blackrock Inc , Get Free Report , Stock Down , Group Holdings , Services Group , Gamunexc Immune Globulin Injection , Flebogamma Immune Globulin Intravenous , Xembify Immune Globulin Subcutaneous , Immune Globulin , Lynspad Alpha , Proteinase Inhibitor , Human Albumin , Plasbumin Albumin , Grifols Daily ,

Short Interest in Grifols, S.A. (NASDAQ:GRFS) Expands By 6.7%

Grifols, S.A. (NASDAQ:GRFS – Get Free Report) was the target of a significant increase in short interest in the month of June. As of June 30th, there was short interest totalling 5,420,000 shares, an increase of 6.7% from the June 15th total of 5,080,000 shares. Based on an average trading volume of 745,400 shares, the […] ....

United States , Albutein Flexbag , Vistaseal Veraseal , Morgan Stanley , First Trust Advisors , Creek Investment Management Inc , Grifols Company Profile , Get Free Report , World Investors , Investment Partners , Creek Investment Management , Trust Advisors , Pictet Asset Management , Asset Management , Gamunexc Immune Globulin Injection , Flebogamma Immune Globulin Intravenous , Xembify Immune Globulin Subcutaneous , Immune Globulin , Lynspad Alpha , Proteinase Inhibitor , Human Albumin , Plasbumin Albumin , Grifols Daily ,